USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Postoperative penile hypoxia is one potential contributor, Pedersen and co-authors noted. The rationale for LI-SWT to treat ...

A recent research presented at the ENDO 2025 revealed that high blood sugar levels can impact men's sexual health. The ...

Erectile dysfunction medication could reduce the risk of Alzheimer’s disease, a new study is suggesting, though some experts cast doubt on the link between the two.

There’s a zap for that. Scientists have unsheathed an electriying new treatment for erectile dysfunction that’s reportedly better than popping a little blue pill — radio waves. New research ...

Read the full paper here. The post Study finds erectile dysfunction for 1 in 5 men even years after Covid infection appeared first on Boing Boing.

People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study.

Of 609 men surveyed, 19% continued to have erectile dysfunction after being hospitalized with COVID-19. Nearly half still had ED after two years.

The study followed over 269,000 participants for five years, and those who were prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s than those who weren’t.

Mounjaro used for weight loss helped people with overweight or obesity lose more than 60 pounds on average when combined with diet and exercise changes.

The health study found medications commonly prescribed for erectile dysfunction are associated with significant reductions in deaths, cardiovascular disease, and dementia ...

New research highlights that 65.8% of diabetic men suffer from erectile dysfunction. Early detection and better diabetes control are key to reducing this common yet serious condition.